Luminescence enhancement effect for the determination of Balofloxacin (cas 127294-70-6) with Balofloxacin (cas 127294-70-6)–europium (III)–sodium dodecylbenzene sulfonate system
-
Add time:08/11/2019 Source:sciencedirect.com
A novel method of luminescence enhancement effect for the determination of Balofloxacin (cas 127294-70-6) (BLFX) was proposed. A new system of the BLFX–Eu3+–SDBS (sodium dodecylbenzene sulfonate) was investigated. It was found that SDBS significantly enhanced the luminescence intensity of the BLFX–Eu3+ complex (about 20-fold). Under the optimized experimental conditions, the system exhibits an excellent linear relationship between the enhanced luminescence intensity and the concentration of BLFX over the range of 1.0×10−8–8.0×10−7 mol L−1 with a correlation coefficient (R) of 0.9994, and the detection limit (3σ) of the method was determined as 2.0×10−9 mol L−1. This method has been successfully applied for the determination of BLFX in pharmaceuticals and human urine/serum samples. Compared with most of the other methods reported, the rapid and simple procedure proposed in the text offers higher sensitivity, wider linear range, and better stability.
We also recommend Trading Suppliers and Manufacturers of Balofloxacin (cas 127294-70-6). Pls Click Website Link as below: cas 127294-70-6 suppliers
Prev:Synthesis and in vitro antimycobacterial activity of Balofloxacin (cas 127294-70-6) ethylene isatin derivatives
Next:High performance liquid chromatography–electrospray ionization mass spectrometric determination of Balofloxacin (cas 127294-70-6) in human plasma and its pharmacokinetics) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- High performance liquid chromatography–electrospray ionization mass spectrometric determination of Balofloxacin (cas 127294-70-6) in human plasma and its pharmacokinetics08/12/2019
- Synthesis and in vitro antimycobacterial activity of Balofloxacin (cas 127294-70-6) ethylene isatin derivatives08/10/2019
- Downregulation of Na(+)–NQR complex is essential for Vibrio alginolyticus in resistance to Balofloxacin (cas 127294-70-6)08/09/2019
- Exploring the aquatic photodegradation of two ionisable fluoroquinolone antibiotics – Gatifloxacin and Balofloxacin (cas 127294-70-6): Degradation kinetics, photobyproducts and risk to the aquatic environment08/08/2019
- Identification and structural characterization of in vivo metabolites of Balofloxacin (cas 127294-70-6) in rat plasma, urine and feces samples using Q-TOF/LC/ESI/MS/MS : In silico toxicity studies08/07/2019
- Characterization of Balofloxacin (cas 127294-70-6)-stressed proteomics and identification of Balofloxacin (cas 127294-70-6)-binding proteins pre-peptidase and integration host factor in Edwardsiella tarda08/06/2019